Myelotoxicity and hepatotoxicity during azathioprine therapy.
about
Using aggregated, de-identified electronic health record data for multivariate pharmacosurveillance: a case study of azathioprine.Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance.Suspected azathioprine induced liver cirrhosis: an unusual side effect.Drug-induced liver graft toxicity caused by cytochrome P450 poor metabolismAzathioprine-induced hepatitis and cholestasis occurring 1 year after treatment.
P2860
Myelotoxicity and hepatotoxicity during azathioprine therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Myelotoxicity and hepatotoxicity during azathioprine therapy.
@en
Myelotoxicity and hepatotoxicity during azathioprine therapy.
@nl
type
label
Myelotoxicity and hepatotoxicity during azathioprine therapy.
@en
Myelotoxicity and hepatotoxicity during azathioprine therapy.
@nl
prefLabel
Myelotoxicity and hepatotoxicity during azathioprine therapy.
@en
Myelotoxicity and hepatotoxicity during azathioprine therapy.
@nl
P2093
P1476
Myelotoxicity and hepatotoxicity during azathioprine therapy.
@en
P2093
de Boer NK
van Bodegraven AA
P304
P577
2005-12-01T00:00:00Z